









Markets
/
Stocks
/
nasdaq-dva
/

DaVita Inc

DVA

140.830USD

-8.390-5.62%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

9.65BMarket Cap

14.00P/E TTM



DaVita Inc

140.830

-8.390-5.62%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of DaVita Inc

Currency: USD Updated: 2026-02-06

Key Insights

DaVita Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 27 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 150.51.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DaVita Inc's Score

Industry at a Glance

Industry Ranking

27 / 75

Overall Ranking

147 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

DaVita Inc Highlights

StrengthsRisks

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Fairly Valued

The company’s latest PE is 14.00, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 36.29M shares, increasing 0.04% quarter-over-quarter.

Held by Scotia Canadian Dividend Fund

Star Investor Scotia Canadian Dividend Fund holds 4.93K shares of this stock.

Analyst Rating

Based on 10 analysts

Hold

Current Rating

150.514

Target Price

+0.87%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of DaVita Inc is 8.54, ranking 20 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 3.62B, representing a year-over-year increase of 9.87%, while its net profit experienced a year-over-year increase of 9.68%.

Score

Industry at a Glance

Previous score

8.54

Change



Financials

5.18

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.82

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.68

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

DaVita Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of DaVita Inc is 5.91, ranking 65 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 14.00, which is 54.44% below the recent high of 21.62 and 25.20% above the recent low of 10.47.

Score

Industry at a Glance

Previous score

5.91

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 27/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of DaVita Inc is 6.00, ranking 62 out of 75 in the Healthcare Providers & Services industry. The average price target is 140.00, with a high of 150.00 and a low of 126.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 10 analysts

Hold

Current Rating

150.514

Target Price

+5.95%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

DaVita Inc

DVA

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of DaVita Inc is 9.44, ranking 6 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 161.17 and the support level at 110.75, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.80

Change

-0.36

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

9.648

Buy

RSI(14)

71.866

Buy

STOCH(KDJ)(9,3,3)

84.624

Overbought

ATR(14)

6.294

High Vlolatility

CCI(14)

127.747

Buy

Williams %R

22.088

Buy

TRIX(12,20)

0.480

Sell

StochRSI(14)

59.659

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

135.606

Buy

MA10

121.361

Buy

MA20

114.080

Buy

MA50

115.665

Buy

MA100

120.715

Buy

MA200

129.966

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of DaVita Inc is 5.00, ranking 49 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 57.41%, representing a quarter-over-quarter decrease of 0.31%. The largest institutional shareholder is Warren Buffett, holding a total of 30.10M shares, representing 43.91% of shares outstanding, with 3.44% decrease in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Berkshire Hathaway Inc.

Star Investors

31.76M

-1.25%

The Vanguard Group, Inc.

Star Investors

4.21M

-10.97%

BlackRock Institutional Trust Company, N.A.

2.40M

-9.18%

Weschler (R Ted)

2.18M

State Street Investment Management (US)

1.83M

-12.35%

Invesco Capital Management LLC

Star Investors

1.40M

+4.25%

Gates Capital Management, Inc.

1.19M

+8.32%

Dimensional Fund Advisors, L.P.

1.09M

+8.83%

Geode Capital Management, L.L.C.

1.02M

-7.78%

LSV Asset Management

927.03K

-1.46%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of DaVita Inc is 8.45, ranking 9 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.95. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.